Global Febrile Neutropenia Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Febrile Neutropenia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Pegfilgrastim
  • 1.2.3 Vancomycin Hydrochloride
  • 1.2.4 Filgrastim Biosimilars
  • 1.2.5 Pegfilgrastim Biosimilars
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Febrile Neutropenia Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Febrile Neutropenia Market Perspective (2016-2027)
• 2.2 Febrile Neutropenia Growth Trends by Regions
  • 2.2.1 Febrile Neutropenia Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Febrile Neutropenia Historic Market Share by Regions (2016-2021)
  • 2.2.3 Febrile Neutropenia Forecasted Market Size by Regions (2022-2027)
• 2.3 Febrile Neutropenia Industry Dynamic
  • 2.3.1 Febrile Neutropenia Market Trends
  • 2.3.2 Febrile Neutropenia Market Drivers
  • 2.3.3 Febrile Neutropenia Market Challenges
  • 2.3.4 Febrile Neutropenia Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Febrile Neutropenia Players by Revenue
  • 3.1.1 Global Top Febrile Neutropenia Players by Revenue (2016-2021)
  • 3.1.2 Global Febrile Neutropenia Revenue Market Share by Players (2016-2021)
• 3.2 Global Febrile Neutropenia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Febrile Neutropenia Revenue
• 3.4 Global Febrile Neutropenia Market Concentration Ratio
  • 3.4.1 Global Febrile Neutropenia Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Febrile Neutropenia Revenue in 2020
• 3.5 Febrile Neutropenia Key Players Head office and Area Served
• 3.6 Key Players Febrile Neutropenia Product Solution and Service
• 3.7 Date of Enter into Febrile Neutropenia Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Febrile Neutropenia Breakdown Data by Type

• 4.1 Global Febrile Neutropenia Historic Market Size by Type (2016-2021)
• 4.2 Global Febrile Neutropenia Forecasted Market Size by Type (2022-2027)

5 Febrile Neutropenia Breakdown Data by Application

• 5.1 Global Febrile Neutropenia Historic Market Size by Application (2016-2021)
• 5.2 Global Febrile Neutropenia Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Febrile Neutropenia Market Size (2016-2027)
• 6.2 North America Febrile Neutropenia Market Size by Type
  • 6.2.1 North America Febrile Neutropenia Market Size by Type (2016-2021)
  • 6.2.2 North America Febrile Neutropenia Market Size by Type (2022-2027)
  • 6.2.3 North America Febrile Neutropenia Market Size by Type (2016-2027)
• 6.3 North America Febrile Neutropenia Market Size by Application
  • 6.3.1 North America Febrile Neutropenia Market Size by Application (2016-2021)
  • 6.3.2 North America Febrile Neutropenia Market Size by Application (2022-2027)
  • 6.3.3 North America Febrile Neutropenia Market Size by Application (2016-2027)
• 6.4 North America Febrile Neutropenia Market Size by Country
  • 6.4.1 North America Febrile Neutropenia Market Size by Country (2016-2021)
  • 6.4.2 North America Febrile Neutropenia Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Febrile Neutropenia Market Size (2016-2027)
• 7.2 Europe Febrile Neutropenia Market Size by Type
  • 7.2.1 Europe Febrile Neutropenia Market Size by Type (2016-2021)
  • 7.2.2 Europe Febrile Neutropenia Market Size by Type (2022-2027)
  • 7.2.3 Europe Febrile Neutropenia Market Size by Type (2016-2027)
• 7.3 Europe Febrile Neutropenia Market Size by Application
  • 7.3.1 Europe Febrile Neutropenia Market Size by Application (2016-2021)
  • 7.3.2 Europe Febrile Neutropenia Market Size by Application (2022-2027)
  • 7.3.3 Europe Febrile Neutropenia Market Size by Application (2016-2027)
• 7.4 Europe Febrile Neutropenia Market Size by Country
  • 7.4.1 Europe Febrile Neutropenia Market Size by Country (2016-2021)
  • 7.4.2 Europe Febrile Neutropenia Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Febrile Neutropenia Market Size (2016-2027)
• 8.2 Asia-Pacific Febrile Neutropenia Market Size by Type
  • 8.2.1 Asia-Pacific Febrile Neutropenia Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Febrile Neutropenia Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Febrile Neutropenia Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Febrile Neutropenia Market Size by Application
  • 8.3.1 Asia-Pacific Febrile Neutropenia Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Febrile Neutropenia Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Febrile Neutropenia Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Febrile Neutropenia Market Size by Region
  • 8.4.1 Asia-Pacific Febrile Neutropenia Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Febrile Neutropenia Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Febrile Neutropenia Market Size (2016-2027)
• 9.2 Latin America Febrile Neutropenia Market Size by Type
  • 9.2.1 Latin America Febrile Neutropenia Market Size by Type (2016-2021)
  • 9.2.2 Latin America Febrile Neutropenia Market Size by Type (2022-2027)
  • 9.2.3 Latin America Febrile Neutropenia Market Size by Type (2016-2027)
• 9.3 Latin America Febrile Neutropenia Market Size by Application
  • 9.3.1 Latin America Febrile Neutropenia Market Size by Application (2016-2021)
  • 9.3.2 Latin America Febrile Neutropenia Market Size by Application (2022-2027)
  • 9.3.3 Latin America Febrile Neutropenia Market Size by Application (2016-2027)
• 9.4 Latin America Febrile Neutropenia Market Size by Country
  • 9.4.1 Latin America Febrile Neutropenia Market Size by Country (2016-2021)
  • 9.4.2 Latin America Febrile Neutropenia Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Febrile Neutropenia Market Size (2016-2027)
• 10.2 Middle East & Africa Febrile Neutropenia Market Size by Type
  • 10.2.1 Middle East & Africa Febrile Neutropenia Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Febrile Neutropenia Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Febrile Neutropenia Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Febrile Neutropenia Market Size by Application
  • 10.3.1 Middle East & Africa Febrile Neutropenia Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Febrile Neutropenia Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Febrile Neutropenia Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Febrile Neutropenia Market Size by Country
  • 10.4.1 Middle East & Africa Febrile Neutropenia Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Febrile Neutropenia Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Xenetic Biosciences, Inc. (XBIO)
  • 11.1.1 Xenetic Biosciences, Inc. (XBIO) Company Details
  • 11.1.2 Xenetic Biosciences, Inc. (XBIO) Business Overview
  • 11.1.3 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Introduction
  • 11.1.4 Xenetic Biosciences, Inc. (XBIO) Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.1.5 Xenetic Biosciences, Inc. (XBIO) Recent Development
• 11.2 Richter Gedeon Nyrt.
  • 11.2.1 Richter Gedeon Nyrt. Company Details
  • 11.2.2 Richter Gedeon Nyrt. Business Overview
  • 11.2.3 Richter Gedeon Nyrt. Febrile Neutropenia Introduction
  • 11.2.4 Richter Gedeon Nyrt. Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.2.5 Richter Gedeon Nyrt. Recent Development
• 11.3 Amgen Inc.
  • 11.3.1 Amgen Inc. Company Details
  • 11.3.2 Amgen Inc. Business Overview
  • 11.3.3 Amgen Inc. Febrile Neutropenia Introduction
  • 11.3.4 Amgen Inc. Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.3.5 Amgen Inc. Recent Development
• 11.4 Hospira, Inc.
  • 11.4.1 Hospira, Inc. Company Details
  • 11.4.2 Hospira, Inc. Business Overview
  • 11.4.3 Hospira, Inc. Febrile Neutropenia Introduction
  • 11.4.4 Hospira, Inc. Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.4.5 Hospira, Inc. Recent Development
• 11.5 Eli Lilly and Company
  • 11.5.1 Eli Lilly and Company Company Details
  • 11.5.2 Eli Lilly and Company Business Overview
  • 11.5.3 Eli Lilly and Company Febrile Neutropenia Introduction
  • 11.5.4 Eli Lilly and Company Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.5.5 Eli Lilly and Company Recent Development
• 11.6 USV Private Limited
  • 11.6.1 USV Private Limited Company Details
  • 11.6.2 USV Private Limited Business Overview
  • 11.6.3 USV Private Limited Febrile Neutropenia Introduction
  • 11.6.4 USV Private Limited Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.6.5 USV Private Limited Recent Development
• 11.7 Aequus BioPharma, Inc.
  • 11.7.1 Aequus BioPharma, Inc. Company Details
  • 11.7.2 Aequus BioPharma, Inc. Business Overview
  • 11.7.3 Aequus BioPharma, Inc. Febrile Neutropenia Introduction
  • 11.7.4 Aequus BioPharma, Inc. Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.7.5 Aequus BioPharma, Inc. Recent Development
• 11.8 Taiho Pharmaceutical Co., Ltd.
  • 11.8.1 Taiho Pharmaceutical Co., Ltd. Company Details
  • 11.8.2 Taiho Pharmaceutical Co., Ltd. Business Overview
  • 11.8.3 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Introduction
  • 11.8.4 Taiho Pharmaceutical Co., Ltd. Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.8.5 Taiho Pharmaceutical Co., Ltd. Recent Development
• 11.9 BeyondSpring Inc.
  • 11.9.1 BeyondSpring Inc. Company Details
  • 11.9.2 BeyondSpring Inc. Business Overview
  • 11.9.3 BeyondSpring Inc. Febrile Neutropenia Introduction
  • 11.9.4 BeyondSpring Inc. Revenue in Febrile Neutropenia Business (2016-2021)
  • 11.9.5 BeyondSpring Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer